Pharmacological and environmental factors in primary angle-closure glaucoma

British Medical Bulletin
Ian Subak-SharpePaul J Foster

Abstract

A large number of drug classes have now been reported to provoke angle closure in high-risk individuals. The mechanism of action can be generalized into three main categories: sympathomimetic, parasympatholytic and idiosyndratic reactions. This review of the ophthalmic literature provides a clinical summary of primary angle-closure glaucoma (PACG) and its management. External stimuli (pharmacological and environmental) may induce acute, and more often, asymptomatic angle closure, which carries a significant risk of glaucoma. Whenever in doubt, patients at risk of PACG who are starting on drug therapy known to provoke angle closure or aggravate the condition should be referred for detailed gonioscopic examination of the anterior chamber by an ophthalmologist. AREAS FOR DEVELOPING RESEARCH: The use of new imaging methods such as anterior segment optical coherence tomography to assess the presence or risk of angle closure is gaining popularity, and may offer a more rapid method of identifying people who are at risk of sight loss from angle-closure glaucoma precipitated by non-ophthalmological medication.

References

Oct 1, 1979·Archives of Ophthalmology·P T Hung, L H Chou
Aug 1, 1977·The British Journal of Ophthalmology·J S Hillman, J D Turner
Feb 1, 1976·The British Journal of Ophthalmology·R Mapstone
Jan 1, 1992·Ophthalmic Plastic and Reconstructive Surgery·J L Gayton, J K Ledford
Jan 4, 1992·BMJ : British Medical Journal·P ShahJ M Gibson
Feb 1, 1992·Postgraduate Medical Journal·K M MulpeterC Burke
Dec 1, 1991·Journal of Epidemiology and Community Health·J M TeikariI Raivio
Aug 1, 1991·Archives of Internal Medicine·G J BerdyL W Hirst
May 1, 1990·The British Journal of Ophthalmology·P CorridanA C Williams
Apr 1, 1990·Acta Ophthalmologica·P P Kearns, B J Dhillon
Dec 1, 1987·The British Journal of Ophthalmology·R S Edwards
Jan 1, 1987·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·J TeikariM Nurminen
Apr 15, 1986·American Journal of Ophthalmology·S R HookJ D Goosey
Mar 1, 1985·Archives of Ophthalmology·D T FazioR E Christensen
Jan 1, 1985·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·R DavidY Yassur
Mar 1, 1973·The British Journal of Ophthalmology·J Gloster, D Poinoosawmy
Jan 1, 1974·British Journal of Plastic Surgery·M F Green, S W Kadri
Sep 1, 1984·Ophthalmology·A L Robin, I P Pollack
Jul 1, 1982·American Journal of Ophthalmology·J A Bovino, D F Marcus
Aug 1, 1982·American Journal of Ophthalmology·R Ritch
Oct 1, 1995·Archives of Ophthalmology·J D Geanon, T W Perkins
Sep 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I G Rennie
Jan 1, 1994·Archives of Ophthalmology·R RitchF Kurata
Jun 15, 1993·American Journal of Ophthalmology·J T FanR R Burk
Jan 1, 1996·Archives of Ophthalmology·A S Markovits
Jan 1, 1995·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·P DenisS Touameur
Feb 17, 1996·Lancet·A L SnyderP D Thompson
Jun 1, 1996·Archives of Ophthalmology·A Azuara-BlancoA K Terebuh
Sep 1, 1996·American Journal of Ophthalmology·J D Mitchell, A L Schwartz
Oct 1, 1996·Archives of Ophthalmology·P J FosterG J Johnson
Nov 1, 1996·Catheterization and Cardiovascular Diagnosis·J S MandakE K Smith
Mar 1, 1997·The Journal of Clinical Psychiatry·C F LewisR Tandon
Mar 1, 1997·The British Journal of Ophthalmology·J F KirwanM Teimory
May 10, 1997·BMJ : British Medical Journal·T Eke, A K Bates
May 10, 1997·BMJ : British Medical Journal·S J Benbow, G Gill
Mar 11, 1998·Journal of Glaucoma·D TallutoS Allee
May 23, 1998·British Journal of Urology·V C Sung, P G Corridan
Aug 6, 1999·The Journal of Laryngology and Otology·C K HariR G Nair
Jun 28, 2000·Experimental Eye Research·C CostagliolaN Pisanti
Aug 18, 2000·Journal of Cataract and Refractive Surgery·T V RobertsM T Coroneo
Sep 27, 2000·American Journal of Ophthalmology·D S Rho
May 8, 2001·Eye·V Barrett, T Jordan

❮ Previous
Next ❯

Citations

Jan 30, 2013·The Journal of Emergency Medicine·Matthew BivensAshleigh Hegedus
Dec 4, 2015·International Journal of Molecular Sciences·Gloria RobertiFrancesco Oddone
Jul 29, 2011·Clinical & Experimental Ophthalmology·Dandan WangShan Lin
Feb 24, 2012·Clinical & Experimental Ophthalmology·David S FriedmanMingguang He
Dec 22, 2010·Anesthesia and Analgesia·Steven Gayer
Jul 2, 2019·Clinical Medicine Insights. Case Reports·Tal PazHana Leiba
Feb 20, 2021·CNS Drugs·Neeranjali S JainRichard J Symes
Mar 18, 2021·The Application of Clinical Genetics·Altaf A Kondkar
Aug 31, 2021·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Yanzhen LiFanglei Yu
Feb 11, 2011·Current Opinion in Ophthalmology
Dec 23, 2021·Ophthalmology·Steven J GeddeUNKNOWN American Academy of Ophthalmology Preferred Practice Pattern Glaucoma Panel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved